FOLR1 and ovarian cancer: A total of 150 patients were infused, with 109 patients analyzed for the primary and secondary endpoints, and it was found that 33% of patients had ≥1  FRα+ ovarian cancer lesion detected by intraoperative fluorescence imaging that was not originally planned for resection based on white light and palpation.